MISSLING CHRISTOPHER U 4
4 · ANAVEX LIFE SCIENCES CORP. · Filed Apr 1, 2024
Insider Transaction Report
Form 4
MISSLING CHRISTOPHER U
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-03-28−73,380→ 0 totalExercise: $1.32From: 2014-05-08Exp: 2024-05-08→ Common Stock (73,380 underlying) - Exercise/Conversion
Common Stock
2024-03-28$1.32/sh+73,380$96,862→ 1,323,590 total - Sale
Common Stock
2024-03-28$5.11/sh−73,380$374,972→ 1,250,210 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.03 to $5.195, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.